| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Paul Mintz is Director at AURX. Paul Mintz's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $138K at current prices.
Paul Mintz has 8 Form 4 filings on record from May 2017 to June 2026, all as Director at Nuo Therapeutics (AURX), 2017–2026.
The 11 reported transactions were 7 option or other derivative awards, 2 option exercises and 2 tax withholdings.
There are no priced open-market purchases or sales on record, so none of these filings shows a decision to buy or sell shares in the market.
No transactions found
Try adjusting your filters or search criteria